We are very happy to announce that the BOOSTB4 trial has completed its final dosing. All doses of mesenchymal stem cells (MSCs) have been successfully administered to the participating children, suffering from Osteogenesis Imperfecta (OI).
A massive thank you to everyone that has worked so hard and contributed so much to making the BOOSTB4 trial a success, and a special heartfelt recognition to all the children and families that have taken part in the trial.